Actual Aspects of Sepsis
Abstract
Cases of sepsis with bacteriemia detected in the S.P. Botkin State Clinical Hospital within 2000-2007 were analysed. The sources of the bacteriemia, the etiological pattern of the pathogens and their susceptibility to antibacterials were estimated. The study enrolled 256 patients with sepsis. The antibiotic susceptibility of 227 isolates from the blood samples was tested. More than a half of the infection sources was detected in the organs of the respiratory tract and abdominal cavity. All the grampositive pathogens were susceptible to vancomycin and linesolid. The overwhelming majority of the enterococcal isolates proved to be susceptible to carbapenem and cefepim.
About the Authors
K. P. Gruver
Russian Academy of Postgraduate Medical Training, Moscow
Russian Federation
Russian Federation
V. B. Beloborodov
Russian Academy of Postgraduate Medical Training, Moscow
Russian Federation
Russian Federation
T. N. Kuzmenko
Russian Academy of Postgraduate Medical Training, Moscow
Russian Federation
Russian Federation
References
1. Грачев С.В., Малое С.Г., Городнова Е.А. Современные аспекты патогенеза сепсиса. Тер. архив. 2003; 11: 84-89.
2. Белобородов В.Б. Сепсис - современная проблема клинической медицины. РМЖ 1997; 5: 24: 326-338.
3. Белобородов В.Б. Сепсис. Методическое руководство. М.: 2000; 13.
4. Angus D.C., Linde-Zwirble W.T., Lidicker J. et al. Epidemiology of severe sepsis in United States: analysis of incidence, outcome, and assotiated costs of care. Crit Care Med 2001; 29: 1303-1310.
5. American College of Chest Physicians. Society of Clinical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Ibid 1992; 20: 6: 864-874.
6. Сепсис в начале XXI века / Под редакцией Савельева В.С., Гельфанда Б.Р. М.: 2006; 172.
7. Bone R.C. Let us agree on terminology: definition of sepsis. Crit. Care Med. 1991; 19: 973-976.
8. Мороз В.В., Лукач В.H., Шифман Е.М. и др. Сепсис. Клинико-патофизиологические аспекты интенсивной терапии. Петрозавоздск. 2004; 292.
9. Arneborn P., Hallen J. Lakartidningen 1990; 87: 2345-2347.
10. Клясова Г.А. Инфекции при гемобластозах и депрессиях кроветворения: клиника, диагностика, лечение. Автореферат.. дис. докт.мед.наук. М.: 2009; 41.
11. Белобородова Н.В. Цефалоспорины IV поколения в лечении тяжёлых инфекций у детей. Consilium Medicum 2000; 2: 4: 15-19.
12. Goossens H. The role of cefepime in preserving and restoring in vitro bacterial susceptibility patterns. Infect Dis Clin Pract 1999; 5: 35-43.
13. Состояние антибиотикорезистентности грамотрицательных возбудителей нозокомиальных инфекций в отделениях интенсивной терапии. Межведомственный научный совет по внутрибольничным инфекциям при РАМН и Минздраве РФ, Межрегиональной ассоциации по клинической микробиологии и антимикробной химиотерапии. 1997.
14. Chastre J., Trouillet J.L. Nosocomial pneumonia: guidelines for initial management and empirical treatment. Eur Res Mon 1997; 3: 101-117.
Review
For citations:
Gruver K.P., Beloborodov V.B., Kuzmenko T.N. Actual Aspects of Sepsis. Antibiot Khimioter = Antibiotics and Chemotherapy. 2011;56(3-4):35-40. (In Russ.)
Views:
336
Email this article 